EXAS: Exact Sciences (EXAS) announced that it received all regulatory approvals and clearances required to consummate the merger. The merger is anticipated to close on March 23, 2026.
KW: Kennedy-Wilson (KW) filed the preliminary proxy statement for its acquisition by CEO McMorrow and Fairfax. The company expects the merger to be completed in the second quarter of 2026.
CVGW: Calavo Growers (CVGW) filed a definitive proxy statement. The companies expect the merger to be completed in the third quarter of 2026.
Only plus or premium subscribers can access this post.
Subscribe today.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
